Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan.
Division of Pulmonary and Critical Care Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Int J Mol Sci. 2019 Nov 21;20(23):5848. doi: 10.3390/ijms20235848.
Adaptive support ventilation (ASV) is a closed-loop ventilation, which can make automatic adjustments in tidal volume (V) and respiratory rate based on the minimal work of breathing. The purpose of this research was to study whether ASV can provide a protective ventilation pattern to decrease the risk of ventilator-induced lung injury in patients of acute respiratory distress syndrome (ARDS). In the clinical study, 15 ARDS patients were randomly allocated to an ASV group or a pressure-control ventilation (PCV) group. There was no significant difference in the mortality rate and respiratory parameters between these two groups, suggesting the feasible use of ASV in ARDS. In animal experiments of 18 piglets, the ASV group had a lower alveolar strain compared with the volume-control ventilation (VCV) group. The ASV group exhibited less lung injury and greater alveolar fluid clearance compared with the VCV group. Tissue analysis showed lower expression of matrix metalloproteinase 9 and higher expression of claudin-4 and occludin in the ASV group than in the VCV group. In conclusion, the ASV mode is capable of providing ventilation pattern fitting into the lung-protecting strategy; this study suggests that ASV mode may effectively reduce the risk or severity of ventilator-associated lung injury in animal models.
适应性支持通气(ASV)是一种闭环通气,可根据最小呼吸功自动调整潮气量(V)和呼吸频率。本研究旨在探讨 ASV 是否能提供保护性通气模式,降低急性呼吸窘迫综合征(ARDS)患者呼吸机相关性肺损伤的风险。在临床研究中,将 15 例 ARDS 患者随机分为 ASV 组或压力控制通气(PCV)组。两组患者的死亡率和呼吸参数无显著差异,表明 ASV 可安全用于 ARDS。在 18 头小猪的动物实验中,与容量控制通气(VCV)组相比,ASV 组的肺泡应变较低。与 VCV 组相比,ASV 组的肺损伤程度较轻,肺泡液清除率较高。组织分析显示,ASV 组基质金属蛋白酶 9 的表达较低,claudin-4 和 occludin 的表达较高。总之,ASV 模式能够提供符合肺保护策略的通气模式;本研究表明,ASV 模式可能有效降低动物模型中呼吸机相关性肺损伤的风险或严重程度。